Latest news
FDA Approves Jideytro for Previously Treated ROS1-Positive Lung Cancer - news.cancerconnect.comnews.cancerconnect.com · Wed, 05 Aug 2026 03:51:34 GMTFDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance - OncodailyOncodaily · Wed, 29 Jul 2026 11:32:06 GMTJideytro Approved for Previously Treated ROS1-Positive NSCLC - Clinical Oncology NewsClinical Oncology News · Mon, 27 Jul 2026 07:00:00 GMT